{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:22:09Z","timestamp":1793330529035,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.japh.2021.10.026","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T16:52:37Z","timestamp":1635180757000},"page":"546-550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of medically unsupervised activated charcoal use a cause for concern in celiac disease?"],"prefix":"10.1016","volume":"62","author":[{"given":"Bryan","family":"Espinoza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zingale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9289-3840","authenticated-orcid":false,"given":"Georgina","family":"Rubal-Peace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.japh.2021.10.026_bib1","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12916-019-1380-z","article-title":"Celiac disease: a comprehensive current review","volume":"17","author":"Caio","year":"2019","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.japh.2021.10.026_bib2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archinte.163.3.286","article-title":"Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study","volume":"163","author":"Fasano","year":"2003","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.japh.2021.10.026_bib3","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/ajg.2012.219","article-title":"The prevalence of celiac disease in the United States","volume":"107","author":"Rubio-Tapia","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.japh.2021.10.026_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/2050640614559263","article-title":"The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis","volume":"2","author":"Ciacci","year":"2015","journal-title":"United European Gastroenterol J"},{"issue":"42","key":"10.1016\/j.japh.2021.10.026_bib5","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.3748\/wjg.v18.i42.6036","article-title":"Celiac disease: prevalence, diagnosis, pathogenesis and treatment","volume":"18","author":"Gujral","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.japh.2021.10.026_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/ajcn\/69.3.354","article-title":"The widening spectrum of celiac disease","volume":"69","author":"Murray","year":"1999","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.japh.2021.10.026_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00394-016-1238-5","article-title":"Celiac disease: understanding the gluten-free diet","volume":"56","author":"Bascu\u00f1\u00e1n","year":"2017","journal-title":"Eur J Nutr"},{"issue":"3","key":"10.1016\/j.japh.2021.10.026_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.gastrohep.2017.12.002","article-title":"New coeliac disease treatments and their complications","volume":"41","author":"Vaquero","year":"2018","journal-title":"Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.japh.2021.10.026_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4292\/wjgpt.v6.i4.207","article-title":"Age-related differences in celiac disease: specific characteristics of adult presentation","volume":"6","author":"Vivas","year":"2015","journal-title":"World J Gastrointest Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.japh.2021.10.026_bib10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.yapd.2008.07.001","article-title":"Celiac disease: pathophysiology, clinical manifestations, and associated autoimmune conditions","volume":"55","author":"Barker","year":"2008","journal-title":"Adv Pediatr"},{"issue":"1","key":"10.1016\/j.japh.2021.10.026_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF03259930","article-title":"Oral activated charcoal in the treatment of intoxications","volume":"3","author":"Neuvonen","year":"1988","journal-title":"Med Toxicol"},{"issue":"9612","key":"10.1016\/j.japh.2021.10.026_bib12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(08)60270-6","article-title":"Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial","volume":"371","author":"Eddleston","year":"2008","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.japh.2021.10.026_bib13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/qjmed\/hci102","article-title":"A\u00a0randomized clinical trial of activated charcoal for the routine management of oral drug overdose","volume":"98","author":"Cooper","year":"2005","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.japh.2021.10.026_bib14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/bcp.12793","article-title":"Activated charcoal for acute overdose: a reappraisal","volume":"81","author":"Juurlink","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.japh.2021.10.026_bib15","series-title":"Critical Care Nephrology","first-page":"600","article-title":"Poisoning: Kinetics to Therapeutics","author":"Jian-Da","year":"2019"},{"issue":"2","key":"10.1016\/j.japh.2021.10.026_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.fm.2006.07.004","article-title":"Chemistry of gluten proteins","volume":"24","author":"Wieser","year":"2007","journal-title":"Food Microbiol"},{"key":"10.1016\/j.japh.2021.10.026_bib17","series-title":"Adherence to the Gluten-Free Diet and Celiac Disease Patient Outcomes: Real World Evidences from an International Patient Registry, iCureCeliac","author":"Drahos","year":"2019"},{"issue":"7","key":"10.1016\/j.japh.2021.10.026_bib18","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3109\/15563659709162569","article-title":"Position statement: single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists","volume":"35","author":"Chyka","year":"1997","journal-title":"J\u00a0Toxicol Clin Toxicol"},{"issue":"2","key":"10.1016\/j.japh.2021.10.026_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1081\/CLT-51867","article-title":"American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position paper: single-dose activated charcoal","volume":"43","author":"Chyka","year":"2005","journal-title":"Clin Toxicol (Phila)"},{"issue":"18","key":"10.1016\/j.japh.2021.10.026_bib20","first-page":"311","article-title":"The use of activated charcoal to treat intoxications","volume":"116","author":"Zellner","year":"2019","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"10.1016\/j.japh.2021.10.026_bib21","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/apt.13725","article-title":"Symptomatic suspected gluten exposure is common among patients with coeliac disease on a gluten-free diet","volume":"44","author":"Silvester","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.japh.2021.10.026_bib22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1464-410X.2002.02996.x","article-title":"Lower urinary tract symptoms: social influence is more important than symptoms in seeking medical care","volume":"90","author":"Wolters","year":"2002","journal-title":"BJU Int"},{"issue":"10","key":"10.1016\/j.japh.2021.10.026_bib23","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.2607","article-title":"Internet and social media for health-related information and communication in health care: preferences of the Dutch general population","volume":"15","author":"Van de Belt","year":"2013","journal-title":"J\u00a0Med Internet Res"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319121004453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319121004453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:50:39Z","timestamp":1761544239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319121004453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1544319121004453"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2021.10.026","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of medically unsupervised activated charcoal use a cause for concern in celiac disease?","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2021.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}